The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–310 of 310
The role of APOE polymorphisms in late-onset dementias
Corder, E. H., Lannfelt, L., Bogdanović, N., Fratiglioni, L., & Mori, H. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050223 · Cited by 91
Martínez-Serrano, A., & Björklund, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1858 · Cited by 87
Hellström‐Lindahl, E., Moore, H., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740777.x · Cited by 86
Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain
Müller, D., Mendla, K. D., Farber, S. A., & Nitsch, R. M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00038-6 · Cited by 84
Hellweg, R., Gericke, C. A., Jendroska, K., Hartung, H.-D., & Cervós‐Navarro, J. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00088-4 · Cited by 82
Slack, B. E., Breu, J., Petryniak, M. A., Srivastava, K., & Wurtman, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8337 · Cited by 81
Sato, A., Sato, Y., & Uchida, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.004 · Cited by 80
Julka, D., Sandhir, R., & Gill, K. D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052157.x · Cited by 80
Arendt, T. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_13 · Cited by 79
Self-citationSchliebs, R., Roβner, S., & Bigl, V. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62109-3 · Cited by 78
Self-citationSlack, B. E. (2000) · Biochemical Journal · doi:10.1042/bj3480381 · Cited by 78
Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer??s Disease?
Giacobini, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115020-00001 · Cited by 78
DNA mutations associated with the human butyrylcholinesterase J-variant.
Bartels, C. F., James, K., & Du, B. N. L. (1992) · PubMed · Cited by 77
Salehi, A., Ocampo, M., Verhaagen, J., & Swaab, D. F. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7252 · Cited by 77
Immunopathogenesis of Psoriasis
Ozawa, M., & Aiba, S. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010043343868 · Cited by 77
Lacalle, S. D., Cooper, J. D., Svendsen, C. N., Dunnett, S. B., & Sofroniew, M. V. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00239-4 · Cited by 76
Liskowsky, W., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.010 · Cited by 76
Self-citationFodero, L. R., Mok, S. S., Lošić, D., Martin, L. L., Aguilar, M., Barrow, C. J., Livett, B. G., & Small, D. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02296.x · Cited by 75
CHOLINERGIC ‘BLOCKADE’ AS A MODEL OF THE COGNITIVE DEFICITS IN ALZHEIMER'S DISEASE
CHRISTENSEN, H., MALTBY, N., JORM, A. F., CREASEY, H., & BROE, G. A. (1992) · Brain · doi:10.1093/brain/115.6.1681 · Cited by 74 · cited 2×
“humans (Christensen et al., 1992; Molchan et al., 1992), providing evidence for the important role of the central”
BackgroundAdvanced glycation end products in neurodegeneration: More than early markers of oxidative stress?
Münch, G. W., Gerlach, M., Sian, J., Wong, A. O., & Riederer, P. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440713 · Cited by 73
Bontempi, B., Whelan, K. T., Risbrough, V. B., Lloyd, G. K., & Menzaghi, F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300150 · Cited by 72
The pharmacology of amyloid precursor protein processing
Racchi, M., & Govoni, S. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00158-4 · Cited by 72
Morphological substrates of mental dysfunction in Lewy body disease: an update
Jellinger, K. A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_21 · Cited by 72
The Cholinergic Neuronal Phenotype in Alzheimer's Disease
Blusztajn, J. K., & Berse, B. (2000) · Metabolic Brain Disease · doi:10.1007/bf02680013 · Cited by 71
Functional Neurochemistry of Alzheimers Disease
Gsell, W., Jungkunz, G., & Riederer, P. F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043386473 · Cited by 71
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies
Perry, E., McKeith, I., & Ballard, C. (2003) · Neurology · doi:10.1212/01.wnl.0000068336.84399.9e · Cited by 70
Roβner, S., Schliebs, R., Härtig, W., & Bigl, V. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02002-9 · Cited by 70
Self-citationLi, X., Song, L., & Jope, R. S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-05914.1996 · Cited by 69
Münch, G. W., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260940 · Cited by 69
Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells
Heinitz, K., Beck, M., Schliebs, R., & Perez-Polo, J. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04015.x · Cited by 68
Self-citationLee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67
Alzheimer plaques and cortical cholinergic innervation
Mesulam, M. M. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90242-3 · Cited by 65
Molecular interactions of acetylcholinesterase with senile plaques
Inestrosa, N. C., & Alarcón, R. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(99)80002-3 · Cited by 63
Guan, Z. Z., Miao, H., Tian, J., Unger, C., Nordberg, A. K., & Zhang, X. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100017 · Cited by 63
Efthimiopoulos, S., Vassilacopoulou, D., Ripellino, J. A., Tezapsidis, N., & Robakis, N. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8046 · Cited by 63
Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs
Szutowicz, A., Bielarczyk, H., Gul‐Hinc, S., Ronowska, A., Pawełczyk, T., & Jankowska-Kulawy, A. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9007-4 · Cited by 62
Racchi, M., Sironi, M., Caprera, A., König, G., & Govoni, S. M. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000878 · Cited by 62
In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses
Kuhl, D. E., Koeppe, R. A., Snyder, S. E., Minoshima, S., Frey, K. A., & Kilbourn, M. R. (2005) · Annals of Neurology · doi:10.1002/ana.20672 · Cited by 59
Züchner, T., Perez-Polo, J. R., & Schliebs, R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20152 · Cited by 59
Self-citationTeaktong, T., Graham, A. J., COURT, J. A., Perry, R. H., Jaros, E., Johnson, M., Hall, R., & Perry, E. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.015 · Cited by 59
Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons
Wilcox, B. J., Applegate, M. D., Portera‐Cailliau, C., & Koliatsos, V. E. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903590405 · Cited by 58
Intraparenchymal NGF Infusions Rescue Degenerating Cholinergic Neurons
Tuszynski, M. H. (2000) · Cell Transplantation · doi:10.1177/096368970000900508 · Cited by 58
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons
Wenk, G. L., McGann, K., Mencarelli, A., Hauss‐Wegrzyniak, B., Soldato, P. D., & Fiorucci, S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00523-9 · Cited by 57
Murase, K., Nabeshima, T., Robitaille, Y., Quirion, R., Ogawa, M., & Hayashi, K. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1609 · Cited by 57
Tozaki‐Saitoh, H., Matsumoto, A., Kanno, T., Nagai, K., Nagata, T., Yamamoto, S., & Nishizaki, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00429-1 · Cited by 57
Woolf, N. J. (1997) · Consciousness and Cognition · doi:10.1006/ccog.1997.0319 · Cited by 57
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment
Tasker, A., Perry, E. K., & Ballard, C. G. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.101 · Cited by 57
Neurone loss in the nucleus basalis of meynert in Creutzfeldt-Jakob disease
Arendt, T., Bigl, V., & Arendt, A. (1984) · Acta Neuropathologica · doi:10.1007/bf00689832 · Cited by 54
Self-citationPropentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.014 · Cited by 54
Darreh‐Shori, T., Brimijoin, S., Kadir, A., Almkvist, O., & Nordberg, A. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.013 · Cited by 54
Lahiri, D. K., Utsuki, T., Chen, D., Farlow, M. R., Shoaib, M., Ingram, D. K., & Greig, N. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04178.x · Cited by 54
Utsuki, T., Shoaib, M. C., Holloway, H. W., Ingram, D. K., Wallace, W., Haroutunian, V. H., Sambamurti, K., Lahiri, D. K., & Greig, N. H. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4507 · Cited by 53
Canet-Aviles, R., Anderton, M. J., Hooper, N. M., Turner, A. J., & Vaughan, P. F. T. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00184-5 · Cited by 52
NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis
Dekker, A. J. A. M., Langdon, D. J., Gage, F. H., et al. (1991) · Neuroreport · doi:10.1097/00001756-199110000-00006 · Cited by 52
Bigl, M., Apelt, J., Eschrich, K., & Schliebs, R. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0772-x · Cited by 51
Self-citationWinkler, J., Ramirez, G. A., Thal, L. J., & Waite, J. J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00834.2000 · Cited by 51
Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons
Szutowicz, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10040 · Cited by 50
A primate model of Alzheimer's disease
Wenk, G. L. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90127-c · Cited by 49
Doering, L. C., & Snyder, E. Y. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000915)61:6<597::aid-jnr3>3.0.co;2-l · Cited by 49
Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic Model
Taylor, B. M., Sarver, R. W., Fici, G. J., Poorman, R. A., Lutzke, B. S., Molinari, A., Kawabe, T. T., Kappenman, K., Buhl, A. E., & Epps, D. E. V. (2003) · Journal of Protein Chemistry · doi:10.1023/a:1023063626770 · Cited by 48
Münch, G. W., Apelt, J., Rosemarie‐Kientsch‐Engel, Stahl, P., Lüth, H. J., & Schliebs, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01837.x · Cited by 44
Self-citationRole of protein kinase Cα in the regulated secretion of the amyloid precursor protein
Racchi, M., Mazzucchelli, M., Pascale, A., Sironi, M., & Govoni, S. M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001204 · Cited by 44
Alzheimer plaques and cortical cholinergic innervation
Arendt, T., & Bigl, V. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90243-5 · Cited by 43
Self-citationCholinergic Activity and Amyloid Precursor Protein Processing in Aging and Alzheimers Disease
Zhang, X. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482499 · Cited by 43
Effects of nicotine on APP secretion and Aβ- or CT105-induced toxicity
Seo, J., Kim, S., Kim, H.-S., Park, C. H., Jeong, S., Lee, J., Choi, S. H., Chang, K., Rah, J., Koo, J., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01124-0 · Cited by 43
Gómez‐Ramos, P., Bouras, C., & Mora´n, M. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91852-x · Cited by 42
Lahiri, D. K., Farlow, M. R., Nürnberger, J. I., & Greig, N. H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48495.x · Cited by 41
Dickinson-Anson, H., Aubert, I., Gage, F. H., & Fisher, L. J. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00543-5 · Cited by 40
Villa, A., Latasa, M. J., & Pascual, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00315.x · Cited by 38
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 38
Differential vulnerability of primary cultured cholinergic neurons to nitric oxide excess
Fass, U., Panickar, K. S., Personett, D. A., Bryan, D., Williams, K., Gonzales, J., Sugaya, K., & McKinney, M. (2000) · Neuroreport · doi:10.1097/00001756-200004070-00007 · Cited by 38
Bigl, M., Bleyl, A., Zedlick, D., Arendt, T., Bigl, V., & Eschrich, K. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031164.x · Cited by 37
Self-citationEffect of PPF and ALCAR on the Induction of NGF- and p75-mRNA and on APP processing in Tg2576 brain
Chauhan, N. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00006-8 · Cited by 37
Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells
Olesen, O. F., Dagø, L., & Mikkelsen, J. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00096-5 · Cited by 37
Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine
Kamal, M. A., Al‐Jafari, A. A., Yu, Q., & Greig, N. H. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.10.003 · Cited by 36
Geula, C., Greenberg, B., & Mesulam, M. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91697-7 · Cited by 36
NGF Promotes Amyloid Precursor Protein Secretion via Muscarinic Receptor Activation
Haring, R., Gurwitz, D., Barg, J., Pinkas‐Kramarski, R., Heldman, E., Pittel, Z., Danenberg, H. D., Wengier, A., Meshulam, H., Marciano, D., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2092 · Cited by 33
Plasticity of Glutamate and GABAA Receptors in the Hippocampus of Patients with Alzheimer's Disease
Armstrong, D. M., Sheffield, R., Mishizen-Eberz, A. J., Carter, T. L., Rissman, R. A., Mizukami, K., & Ikonomović, M. D. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025063811290 · Cited by 32
Araki, W., & Wurtman, R. J. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00050-3 · Cited by 30
Wang, C.-S., Wurtman, R. J., & Lee, R. K. K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02183-1 · Cited by 30
Acetylcholine Receptors and Tau Phosphorylation
Rubio, A., Pérez, M., & Ávila, J. (2006) · Current Molecular Medicine · doi:10.2174/156652406777435444 · Cited by 30
β-Amyloid and Cholinergic Neurons
Doležal, V., & Kašparová, J. (2003) · Neurochemical Research · doi:10.1023/a:1022865121743 · Cited by 30
Guan, Z., Yu, W., Shan, K.-R., Nordman, T., Olsson, J. M., & Nordberg, A. K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10496 · Cited by 29
Seo, H., Ferree, A. W., & Ole Isacson, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01884.x · Cited by 27
The nucleus basalis of Meynert during ageing and in dementing neuropsychiatric disorders
Bigl, V., Arendt, T., & Biesold, D. (1990) · Oxford University Press eBooks · doi:10.1093/oso/9780198542667.003.0015 · Cited by 27
Self-citationBigl, V., & Schliebs, R. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_23 · Cited by 26
Self-citationBarbelivien, A., Bertrand, N., Besret, L., Beley, A., MacKenzie, E. T., & Dauphin, F. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01736-9 · Cited by 26
Sáez‐Valero, J., Fodero, L. R., White, A. R., Barrow, C. J., & Small, D. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04159-8 · Cited by 26
Schätz, C. R., Geula, C., & Mesulam, M. M. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90119-t · Cited by 25
Specificity of interneuronal connections
Frotscher, M. (1992) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(11)80254-2 · Cited by 23
Ballard, C. G., Morris, C. M., Kalaria, R. N., McKeith, I. G., Perry, R., & Perry, E. K. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084705 · Cited by 23
Malo, M., Diebler, M. F., de Carvalho, L. P., Meunier, F.-M., Dunant, Y., Bloc, A., Stinnakre, J., Tomasi, M., Tchélingérian, J., Couraud, P., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731483.x · Cited by 23
Rahimi, O. B., & Juliano, S. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.4.2081 · Cited by 19
Roβner, S., Kumar, A., Witzemann, V., & Schliebs, R. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90213-5 · Cited by 18
Self-citationSchliebs, R., Heidel, K., Apelt, J., Gniezdzinska, M., Kirazov, L., & Szutowicz, A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.014 · Cited by 17
Self-citationMehlhorn, G., Löffler, T., Apelt, J., Roβner, S., Urabe, T., Hattori, N., Nagamatsu, S., Bigl, V., & Schliebs, R. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00078-1 · Cited by 17
Self-citationMoll, G. H., Gsell, W., Wichart, I., Jellinger, K. A., & Riederer, P. F. (1990) · Key topics in brain research · doi:10.1007/978-3-7091-3396-5_24 · Cited by 16
Neurochemical abnormalities in Alzheimer’s disease and Parkinson’s disease — a comparative review
Gsell, W., Strein, I., Krause, U., & Riederer, P. F. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_12 · Cited by 16
Animal Models to Produce Cortical Cholinergic Dysfunction
Schliebs, R., & Bigl, V. (1996) · Methods in neurosciences · doi:10.1016/s1043-9471(96)80108-x · Cited by 15
Self-citationPuoliväli, J. T., Miettinen, R. A., Pradier, L., & Riekkinen, P. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00545-x · Cited by 14
Bigl, M., Beck, M., Bleyl, A., Bigl, V., & Eschrich, K. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00019-x · Cited by 14
The regulation of presenilin‐1 by nerve growth factor
Counts, S., Lah, J. J., & Levey, A. I. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00014.x · Cited by 13
Correlation between Apolipoprotein-E Polymorphism and Alzheimer's Disease Pathology
Cruz-Sánchez, F., Durany, N., Thome, J., Riederer, P. F., & Zambón, D. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-23-404 · Cited by 13
Walch-Solimena, C., Schliebs, R., & Bigl, V. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9138-7_29 · Cited by 10
Self-citationGrigoryan, G., Gray, J. A., Rashid, T., Chadwick, A. J., & Hodges, H. (2000) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2000-00158 · Cited by 10
Pathologische Anatomie der Alzheimer Krankheit
Arendt, T. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_6 · Cited by 9
Self-citationSchliebs, R. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-896-0_4 · Cited by 2
Self-citation(2000) · doi:10.1002/1531-8249(200012)48:6
Yamauchi (2000) · doi:10.1002/1097-4547(20001115)62:4
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Self-citationConnections between sleep and cognition in older adults
Yaffe, K., Falvey, C. M., & Hoang, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70172-3 · Cited by 796
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W.-Y., & Qin, H.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.017 · Cited by 651
Metadata
- Authors
- Schliebs, R., & Arendt, T.
- Venue
- Journal of Neural Transmission
- Published
- 2006-10-13
- Volume
- 113
- Issue
- 11
- Pages
- 1625-1644
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2064111465
- Cited by
- 530
- References
- 310
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.